Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/58774
Full metadata record
DC FieldValueLanguage
dc.contributor.authorP. Kosuwonen_US
dc.contributor.authorM. Lao-arayaen_US
dc.contributor.authorS. Uthaisangsooken_US
dc.contributor.authorC. Layen_US
dc.contributor.authorJ. Bindelsen_US
dc.contributor.authorJ. Knolen_US
dc.contributor.authorP. Chatchateeen_US
dc.date.accessioned2018-09-05T04:30:42Z-
dc.date.available2018-09-05T04:30:42Z-
dc.date.issued2018-01-01en_US
dc.identifier.issn18762891en_US
dc.identifier.issn18762883en_US
dc.identifier.other2-s2.0-85048461228en_US
dc.identifier.other10.3920/BM2017.0110en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048461228&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/58774-
dc.description.abstract© 2018 Wageningen Academic Publishers. Little is known about the impact of nutrition on toddler gut microbiota. The plasticity of the toddler gut microbiota indicates that nutritional modulation beyond infancy could potentially impact its maturation. The objective of this study was to determine the effect of consuming Young Child Formula (YCF) supplemented with short chain galactooligosaccharides and long chain fructooligosaccharides (scGOS/lcFOS, ratio 9:1) and Bifidobacterium breve M-16V on the development of the faecal microbiota in healthy toddlers. A cohort of 129 Thai children aged 1-3 years were included in a randomised controlled clinical study. The children were assigned to receive either YCF with 0.95 g/100 ml of scGOS/lcFOS and 1.8×107cfu/g of B. breve M-16V (Active-YCF) or Control-YCF for 12 weeks. The composition and metabolic activity of the faecal microbiota, and the level of secretory immunoglobulin A were determined in the stool samples. The consumption of Active-YCF increased the proportion of Bifidobacterium (mean 27.3% at baseline to 33.3%, at week 12, P=0.012) with a difference in change from baseline at week 12 between the Active and Control of 7.48% (P=0.030). The consumption of Active-YCF was accompanied with a more acidic intestinal milieu compared to the Control-YCF. The pH value decreased statistically significantly in the Active-YCF group from a median of 7.05 at baseline to 6.79 at week 12 (P < 0.001). The consumption of Active-YCF was associated with a softer pudding-like stool consistency compared to the Control-YCF. At week 6 and week 12, the betweengroup difference in stool consistency was statistically significant (P=0.004 and P < 0.001, respectively). A Young Child Formula supplemented with scGOS/lcFOS and B. breve M-16V positively influences the development of the faecal microbiota in healthy toddlers by supporting higher levels of Bifidobacterium. The synbiotic supplementation is also accompanied with a more acidic intestinal milieu and softer stools.en_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleA synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young childrenen_US
dc.typeJournalen_US
article.title.sourcetitleBeneficial Microbesen_US
article.volume9en_US
article.stream.affiliationsKhon Kaen Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsNaresuan Universityen_US
article.stream.affiliationsDanone Nutricia Reseachen_US
article.stream.affiliationsNutricia Research, Netherlandsen_US
article.stream.affiliationsWageningen University and Research Centreen_US
article.stream.affiliationsKing Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.